Hepato-Billiary Cancer

Hepato-Billiary Cancer

Hepato-biliary cancers are malignancies that affect the liver, bile ducts, and gallbladder. These cancers can significantly impact liver function and overall health, as the liver plays a vital role in digestion, detoxification, and metabolism. Early diagnosis and a well-planned treatment strategy are essential for improving outcomes.

Radiation therapy is increasingly used in the management of hepato-biliary cancers, especially in cases where surgery is not feasible or as part of combined treatment with chemotherapy. Advanced radiation techniques allow precise targeting of the tumor while minimizing exposure to healthy liver tissue and nearby organs.

Common Types of Hepato-Biliary Cancers

  • Hepatocellular carcinoma (primary liver cancer)
  • Cholangiocarcinoma (bile duct cancer)
  • Gallbladder cancer
  • Metastatic liver tumors

Common Symptoms

  • Abdominal pain or swelling
  • Jaundice (yellowing of skin and eyes)
  • Unexplained weight loss
  • Loss of appetite
  • Nausea or vomiting
  • Fatigue and weakness

Treatment Approach

Diagnosis typically involves blood tests, imaging studies such as ultrasound, CT scan, MRI, or PET-CT, and sometimes biopsy to confirm the nature and stage of the disease. Treatment planning is individualized based on tumor location, size, liver function, and overall patient health.

Radiation therapy using advanced techniques such as IMRT, IGRT, or stereotactic body radiation therapy (SBRT) enables high-precision dose delivery while protecting surrounding healthy liver tissue, stomach, and intestines. Treatment may be combined with surgery, chemotherapy, or targeted therapies for optimal results.

With a comprehensive multidisciplinary approach and modern treatment strategies, hepato-biliary cancers can be managed effectively, improving survival outcomes and enhancing quality of life.